1. Home
  2. SBI vs BDSX Comparison

SBI vs BDSX Comparison

Compare SBI & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBI
  • BDSX
  • Stock Information
  • Founded
  • SBI 1992
  • BDSX 2005
  • Country
  • SBI United States
  • BDSX United States
  • Employees
  • SBI N/A
  • BDSX N/A
  • Industry
  • SBI Finance/Investors Services
  • BDSX Precision Instruments
  • Sector
  • SBI Finance
  • BDSX Health Care
  • Exchange
  • SBI Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • SBI 106.2M
  • BDSX 115.4M
  • IPO Year
  • SBI N/A
  • BDSX 2020
  • Fundamental
  • Price
  • SBI $7.57
  • BDSX $0.37
  • Analyst Decision
  • SBI
  • BDSX Strong Buy
  • Analyst Count
  • SBI 0
  • BDSX 4
  • Target Price
  • SBI N/A
  • BDSX $2.83
  • AVG Volume (30 Days)
  • SBI 39.5K
  • BDSX 638.4K
  • Earning Date
  • SBI 01-01-0001
  • BDSX 05-13-2025
  • Dividend Yield
  • SBI 4.52%
  • BDSX N/A
  • EPS Growth
  • SBI N/A
  • BDSX N/A
  • EPS
  • SBI N/A
  • BDSX N/A
  • Revenue
  • SBI N/A
  • BDSX $71,323,000.00
  • Revenue This Year
  • SBI N/A
  • BDSX $32.90
  • Revenue Next Year
  • SBI N/A
  • BDSX $24.65
  • P/E Ratio
  • SBI N/A
  • BDSX N/A
  • Revenue Growth
  • SBI N/A
  • BDSX 45.30
  • 52 Week Low
  • SBI $6.96
  • BDSX $0.45
  • 52 Week High
  • SBI $8.00
  • BDSX $2.04
  • Technical
  • Relative Strength Index (RSI)
  • SBI 48.71
  • BDSX 29.45
  • Support Level
  • SBI $7.52
  • BDSX $0.34
  • Resistance Level
  • SBI $7.75
  • BDSX $0.58
  • Average True Range (ATR)
  • SBI 0.07
  • BDSX 0.06
  • MACD
  • SBI 0.02
  • BDSX -0.01
  • Stochastic Oscillator
  • SBI 50.00
  • BDSX 12.15

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: